<p>2026 年 5 月 18 日东部夏令时间凌晨 4:22（MT Newswires）-- Bio-Rad Laboratories（BIO/B）获得了 Elliott Investment Management 的大额投资，该公司计划推动这家生命科学工具供应商改善其滞后的股票表现，《华尔街日报》周日援引知情人士的话报道。</p>
<p>据报道，Elliott 还持有德国实验室设备制造商 Sartorius 的股份，而 Bio-Rad Laboratories（BIO/B）在该公司拥有约 50 亿美元的战略投资。</p>
<p>报告称，Bio-Rad Laboratories（BIO/B）股票自 2021 年底疫情高峰以来已下跌超过 70%，因销售和利润疲软，公司表现不及同行。</p>
<p>Elliott Investment Management 未立即回应 MT Newswires 的评论请求。</p>
<p>Bio-Rad Laboratories（BIO/B）股票在周一盘前交易中上涨超过 4%。</p>
<p>（市场聊天新闻来源于全球市场专业人士的对话。这些信息被认为来自可靠来源，但可能包含谣言和猜测。准确性无法保证。）</p>
<p>MT Newswires 不提供投资建议。未经授权的复制是严格禁止的。</p>

Bio-Rad实验室-A

<p>Bio-Rad 实验室获得了 Elliott 投资管理公司的重大投资，旨在提升公司的股票表现。自 2021 年底以来，由于销售和利润下降，Bio-Rad 的股价已暴跌超过 70%。Elliott 还持有 Sartorius 的股份，而 Bio-Rad 在该公司有 50 亿美元的投资。消息公布后，Bio-Rad 的股价在盘前交易中上涨了超过 4%</p>

<p>04:22 AM EDT, 05/18/2026 (MT Newswires) -- Bio-Rad Laboratories ( BIO/B ) has attracted a sizable investment from Elliott Investment Management, which plans to push the life-science tools supplier to improve its lagging stock performance, the Wall Street Journal reported Sunday, citing people familiar with the matter.</p>
<div class="lb-trans"><p>2026 年 5 月 18 日东部夏令时间凌晨 4:22（MT Newswires）-- Bio-Rad Laboratories（BIO/B）获得了 Elliott Investment Management 的大额投资，该公司计划推动这家生命科学工具供应商改善其滞后的股票表现，《华尔街日报》周日援引知情人士的话报道。</p>
</div><p>Elliott also holds a stake in German laboratory equipment maker Sartorius, in which Bio-Rad Laboratories ( BIO/B ) owns a strategic investment valued at about $5 billion, according to the report.</p>
<div class="lb-trans"><p>据报道，Elliott 还持有德国实验室设备制造商 Sartorius 的股份，而 Bio-Rad Laboratories（BIO/B）在该公司拥有约 50 亿美元的战略投资。</p>
</div><p>Bio-Rad Laboratories ( BIO/B ) shares have fallen more than 70% from their pandemic-era peak in late 2021 as sales and profits weakened and the company underperformed peers, the report said.</p>
<div class="lb-trans"><p>报告称，Bio-Rad Laboratories（BIO/B）股票自 2021 年底疫情高峰以来已下跌超过 70%，因销售和利润疲软，公司表现不及同行。</p>
</div><p>Elliott Investment Management did not immediately respond to MT Newswires' request for comment.</p>
<div class="lb-trans"><p>Elliott Investment Management 未立即回应 MT Newswires 的评论请求。</p>
</div><p>Bio-Rad Laboratories ( BIO/B ) shares were over 4% higher in Monday premarket trading.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories（BIO/B）股票在周一盘前交易中上涨超过 4%。</p>
</div><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p>
<div class="lb-trans"><p>（市场聊天新闻来源于全球市场专业人士的对话。这些信息被认为来自可靠来源，但可能包含谣言和猜测。准确性无法保证。）</p>
</div><p>MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</p>
<div class="lb-trans"><p>MT Newswires 不提供投资建议。未经授权的复制是严格禁止的。</p>
</div>

市场传闻：Bio-Rad 实验室吸引了 Elliott 投资，激进投资者推动其进行转型